STOCK TITAN

SOPHiA GENETICS (SOPH) affiliate files to sell 37,000 founders shares on NASDAQ

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

SOPHiA GENETICS reports that an affiliate, acting through Morgan Stanley Smith Barney LLC Executive Financial Services, has filed to sell up to 37,000 shares of common stock classified as founders shares. The proposed sale amount is listed at $234,210.00.

The filing also details prior sales under a Rule 10b5-1 trading plan for Jurgi Camblong, including 65,269 common shares sold on June 30, 2026 for $398,632.27 and 50,069 shares sold on June 26, 2026 for $290,329.01, along with several smaller transactions between May and July 2026.

Positive

  • None.

Negative

  • None.
Proposed shares to be sold 37,000 shares Common stock founders shares in current Form 144
Proposed aggregate sale value $234,210.00 Value associated with 37,000 common shares
10b5-1 sale on 06/30/2026 65,269 shares for $398,632.27 Common stock sold under 10b5-1 plan
10b5-1 sale on 06/26/2026 50,069 shares for $290,329.01 Common stock sold under 10b5-1 plan
10b5-1 sale on 07/20/2026 24,381 shares for $153,445.04 Common stock sold under 10b5-1 plan
Founders Shares financial
"Common | 03/18/2021 | Founders Shares | Issuer"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
10b5-1 regulatory
"10b5-1 Sales for JURGI CAMBLONG La Piece 12"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Form 144 regulatory
"144: Securities Information Common | Morgan Stanley Smith Barney"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Executive Financial Services financial
"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does SOPH’s latest Form 144 filing disclose?

The filing discloses an intent to sell up to 37,000 SOPH common shares of founders stock through Morgan Stanley Smith Barney, with a proposed aggregate sale value of $234,210.00, and lists recent Rule 10b5-1 plan sales.

How many SOPH shares are proposed for sale in this Form 144?

The filer proposes to sell up to 37,000 shares of SOPH common stock. These are described as founders shares and are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, according to the Form 144 disclosure.

What is the aggregate value of SOPH shares covered by the proposed sale?

The proposed sale covers an aggregate value of $234,210.00 in SOPH common shares. This figure is tied to the 37,000 founders shares indicated in the Form 144 filing submitted via Morgan Stanley Smith Barney.

Who is the selling security holder in SOPH’s Form 144?

The sales are associated with Jurgi Camblong, with transactions executed under a 10b5-1 trading plan. The filing notes sales of SOPH common shares from an address in Rolle, Switzerland across multiple dates in May–July 2026.

What recent 10b5-1 sales of SOPH stock are detailed in the filing?

Recent 10b5-1 sales include 65,269 shares for $398,632.27 on June 30, 2026 and 50,069 shares for $290,329.01 on June 26, 2026, plus additional transactions ranging from 1,373 to 24,381 shares in May–July 2026.

On which exchange are the SOPH shares in this Form 144 listed?

The common shares referenced in the Form 144 are listed on NASDAQ. The filing specifies NASDAQ as the trading market for the SOPH common stock covered by the proposed sale and the recent 10b5-1 transactions.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature